EV/EBITDA
-22.44
-0.11-0.49%
Wed, 12 Mar 2025 20:05:05 GMT
Summary
- As of March 13, 2025, MNPR EV/EBITDA is -22.44, with a fall of -0.11 (-0.49%) during the most recent trading day.
- Over the past year, MNPR EV/EBITDA has dropped by -21.63 (-2670.37%).
- MNPR EV/EBITDA is now -7580.00% below its all-time high of 0.30.
Performance
MNPR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MNPR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.5% | +0.5% | +0.5% |
| 1 m1 month | +36.5% | -36.5% | -35.6% |
| 3 m3 months | -31.3% | +31.3% | +29.8% |
| 6 m6 months | -2312.9% | +2162.9% | +732.9% |
| ytdytd | -42.7% | +42.7% | +40.5% |
| 1 y1 year | -2670.4% | +2096.2% | +648.2% |
| 5 y5 years | -32.0% | +113.7% | -24.5% |
MNPR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -11.8% | -35.34 | +36.5% | |
| 3 m | 3-month | -15.73 | -42.7% | -38.58 | +41.8% |
| 6 m | 6-month | -0.93 | -2312.9% | -38.58 | +41.8% |
| 1 y | 1-year | -0.22 | <-9999.0% | -38.58 | +41.8% |
| 3 y | 3-year | 0.30 | -7580.0% | -38.58 | +41.8% |
| 5 y | 5-year | 0.30 | -7580.0% | -38.58 | +41.8% |
| alltime | all time | 0.30 | -7580.0% | -68.78 | +67.4% |
Monopar Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -22.44(+42.7%) |
| 2024 | -15.73(-6392.0%) |
| 2023 | 0.25(-111.7%) |
| Date | Value |
|---|---|
| 2022 | -2.14(-3.2%) |
| 2021 | -2.21(-73.0%) |
| 2020 | -8.20(-78.2%) |
| 2019 | -37.59 |
FAQ
- What is Monopar Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Monopar Therapeutics?
- What is MNPR EV/EBITDA year-to-date change?
- What is Monopar Therapeutics EV/EBITDA year-on-year change?
What is Monopar Therapeutics EV/EBITDA?
The current EV/EBITDA of MNPR is -22.44
What is the all time high EV/EBITDA for Monopar Therapeutics?
Monopar Therapeutics all-time high EV/EBITDA is 0.30
What is MNPR EV/EBITDA year-to-date change?
Monopar Therapeutics EV/EBITDA has changed by -6.71 (-42.66%) since the beginning of the year
What is Monopar Therapeutics EV/EBITDA year-on-year change?
Over the past year, MNPR EV/EBITDA has changed by -21.63 (-2670.37%)